Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$105,000.00

Uncovering the molecular mechanism underlying KDM6A in Kabuki Syndrome

FY 2021-22

Summary
Kabuki Syndrome is a rare genetic disease that affects 1 in 40,000 individuals and is characterized by intellectual disability, abnormal development of the brain and heart, and malformations of the face and skull. Genetic diseases involve errors in patients' DNA. In Kabuki Syndrome, these errors can occur in a specific DNA segment that codes for the KDM6A protein. This protein modifies complexes around which DNA is wrapped, called histones. By modifying histones, KDM6A can signal to the cell to turn on the expression of certain genes. My preliminary results in stem cell models show that when KDM6A is lost, genes involved in making neural cells are reduced. This proposed research thus aims to understand the molecular mechanism that involves KDM6A, KDM6A-associated histone modifications, and certain genes required for making neural cells in order to understand why KDM6A causes Kabuki Syndrome. We will be using genetically engineered stem cells and stem cells derived from Kabuki Syndrome patients' blood samples to investigate our question. We expect to see an increase in a specific kind of histone modification when KDM6A is lost, which could lead to a decrease of neural genes that are normally controlled by KDM6A-associated histone modifications. By uncovering the molecular mechanism underlying KDM6A-caused Kabuki Syndrome, we hope to help clinicians better understand a subgroup of patients who present with developmental abnormalities, and to open doors to the development of potential treatments for this disorder.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
458834
Name
Ni Anjie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Uncovering the molecular mechanism underlying KDM6A in Kabuki Syndrome
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Chip-Seq; Epigenetics; Genetic Engineering; Ipsc Modeling; Kabuki Syndrome; Multiple Congenital Anomalies; Neurogenetics; Personalized Medicine; Rare Disease Genetics; Rna-Seq
Abstract
Kabuki Syndrome is a rare genetic disease that affects 1 in 40,000 individuals and is characterized by intellectual disability, abnormal development of the brain and heart, and malformations of the face and skull. Genetic diseases involve errors in patients' DNA. In Kabuki Syndrome, these errors can occur in a specific DNA segment that codes for the KDM6A protein. This protein modifies complexes around which DNA is wrapped, called histones. By modifying histones, KDM6A can signal to the cell to turn on the expression of certain genes. My preliminary results in stem cell models show that when KDM6A is lost, genes involved in making neural cells are reduced. This proposed research thus aims to understand the molecular mechanism that involves KDM6A, KDM6A-associated histone modifications, and certain genes required for making neural cells in order to understand why KDM6A causes Kabuki Syndrome. We will be using genetically engineered stem cells and stem cells derived from Kabuki Syndrome patients' blood samples to investigate our question. We expect to see an increase in a specific kind of histone modification when KDM6A is lost, which could lead to a decrease of neural genes that are normally controlled by KDM6A-associated histone modifications. By uncovering the molecular mechanism underlying KDM6A-caused Kabuki Syndrome, we hope to help clinicians better understand a subgroup of patients who present with developmental abnormalities, and to open doors to the development of potential treatments for this disorder.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ni, Anjie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2021-22) | Canada Spends